Growth of Home Care Digitization in the United States and Europe
Webinar: 2026 Economic Shifts Amid Geopolitical & Supply Chain Risks
Technologies
- What key growth gaps must be addressed to operationalize AI?
- Align with the clinical workflow automation megatrend for growth.
- Adopt the execution-focused transformation to gain an edge.
- Close key growth gaps to reduce fragmented systems issues.
- How can RCM vendors upgrade value propositions?
- Equip your technology roadmap with Generative AI (GenAI) and ML.
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Eron Kelly
From AI Assistance to Agentic Execution: A Conversation on the Future of Data-driven Healthcare
Eron Kelly
CEO | ConcertAI
Interview with Fumihide Esaka
From Edge AI to Intelligent Healthcare: How Ambiq Is Enabling the Next Generation of Connected Medical Devices
Fumihide Esaka
CEO | Ambiq
Interview with Dr. Nurul Mu’az Bin Omar
Transforming Care, Driving Value: Selgate Healthcare’s Strategy for Patient-centric Care in Malaysia
Dr. Nurul Mu’az Bin Omar
Managing Director & CEO | Selgate Healthcare
Interview with Dr. Sud Agarwal
Reimagining the CRO Model: How iNGENu CRO Is Using AI and Automation to Transform Clinical Trial Execution
Dr. Sud Agarwal
CEO | iNGENu CRO
Interview with Sujay Jadhav
Transforming Real-world Evidence: How Verana Health Is Advancing AI-powered Clinical Evidence
Sujay Jadhav
CEO | Verana Health
Navigating Transformation – Middle East (April 2026 Edition)
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Examine growth avenues in virtual healthcare assistants and biological age tracking & longevity platforms.

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Capture growth across landscapes like self-powered sensors in biomedical applications and AI-enabled clinical trials.
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-driven Multimodal Oncology Platforms
Frost & Sullivan is pleased to announce that BostonGene has been recognized as the 2026 Global Company of the Year in AI-Driven Multimodal Oncology Platforms. This recognition highlights BostonGene’s leadership in improving drug development decisions through its AI foundation model of tumor and immune biology.
Global Pharma Tech Summit 2026: Partnerships are shifting from “growth optional” to “license to operate”
Unmesh Lal, Vice President, Healthcare & Life Sciences, Frost & Sullivan, joined a panel on Global Pharma Industry Outlook & Strategic Partnerships at the Global Pharma Tech Summit 2026 (18–19 May, Radisson Blu Hotel London Heathrow).
From Frost & Sullivan's vantage point, the global pharma space remains in growth mode, $1,627.73B (2025) to $1,722.05B (2026), ~5.8% growth, but the centre of gravity is moving fast. Large molecules are outpacing small molecules in growth, and the winners are increasingly defined by deliverability, evidence, and partner ecosystems, not molecule novelty alone.
How AI, Bioinformatics, and Digital Health Platforms Are Reshaping the Genetic Testing Industry
The global genetic testing industry is expanding rapidly and is projected to grow at a CAGR of 9.8% by 2030. This momentum is pushing providers and vendors to adopt next‑generation sequencing, digital platforms, and AI‑based interpretation at scale. The shift is moving testing away from isolated, lab‑centric models toward integrated, data‑driven workflows that enable faster insights and wider clinical adoption.
Analytics from Frost & Sullivan’s VP of Healthcare & Life Sciences on Abzena Emerging as an Antibody-drug Conjugate (ADC) Contract Development and Manufacturing Organization (CDMO) Leader in the Frost Radar Analysis
The global antibody‑drug conjugate (ADC) landscape is undergoing rapid expansion, fuelled by a surge in clinical pipeline progression, next‑generation payload innovation, and the intensifying need for integrated development and manufacturing partners. Within this competitive environment, Abzena has secured a prominent position in Frost & Sullivan’s Frost Radar™: ADC Contract Development and Manufacturing Organizations, 2025, reflecting the company’s scientific depth, specialized capabilities, and differentiated technology platforms.
How Medicare Advantage CFOs Are Turning Coding Defensibility Into Their Strongest Revenue Strategy
Risk adjustment has been one of the most reliable growth levers in Medicare Advantage (MA) for the better part of a decade. The logic was straightforward: higher risk scores resulted in higher capitated payments from the Centers for Medicare & Medicaid Services (CMS), and health plans invested heavily in retrospective chart reviews, in-home health risk assessments, and coding optimization programs to capture the full acuity of their member populations. The scale of MA enrollment is now massive, with 51% of the eligible Medicare population — a record 35.4 million people — now enrolled.¹
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- Amazon Bets on Health Care AI With Tools for Patients, Doctors
- Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President
- Jardine Matheson to buy Australia's I-MED at $2.4 billion enterprise value in healthcare push
- Bristol Myers partners with Microsoft for AI-driven lung cancer detection
- CVS taps Google Cloud to roll out AI-powered health platform
Frost & Sullivan Institute
Click Here to explore our latest blog on "Bridging Healthcare Inequality: What India Can Learn from Thailand’s Universal Coverage Model".
Capture growth across clinical diagnostics, pharmaceuticals, and clinical laboratory services.
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.
